Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2025 Filed Sep 8, 2025 22:12 UTC |
Roberts David BDirector · President and Director
|
GrantDividend Equivalent Rights · Derivative | 2.7639 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.247 Underlying: Common Stock · 2.7639 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:12 UTC |
Roberts David BDirector · President and Director
|
GrantDividend Equivalent Rights · Derivative | 4.2906 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27.2657 Underlying: Common Stock · 4.2906 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:12 UTC |
Roberts David BDirector · President and Director
|
GrantDividend Equivalent Rights · Derivative | 3.5808 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.8906 Underlying: Common Stock · 3.5808 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:12 UTC |
Roberts David BDirector · President and Director
|
GrantDividend Equivalent Rights · Derivative | 2.7926 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34.1213 Underlying: Common Stock · 2.7926 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:12 UTC |
Roberts David BDirector · President and Director
|
GrantDividend Equivalent Rights · Derivative | 2.7926 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34.8043 Underlying: Common Stock · 2.7926 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:12 UTC |
Roberts David BDirector · President and Director
|
GrantDividend Equivalent Rights · Derivative | 1.3714 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.3792 Underlying: Common Stock · 1.3714 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:12 UTC |
Roberts David BDirector · President and Director
|
GrantDividend Equivalent Rights · Derivative | 0.7211 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.1959 Underlying: Common Stock · 0.7211 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2025 Filed Sep 6, 2025 00:59 UTC |
LeMaitre George WDirector · Chairman and CEO
|
GiftCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,705,803 Read SEC document |
| September 03, 2025 Filed Sep 6, 2025 00:59 UTC |
LeMaitre George WDirector · Chairman and CEO
|
GiftCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,716,403 Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:30 UTC |
Jasinski Lawrence JDirector
|
SaleCommon Stock | 976 | $92.78 | $90,553.28 |
DisclosureSEC source: 0001437749-25-026964 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,773 Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,713 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · derivative · entry 9 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,672 Underlying: Common Stock · 6,713 shares Expires 2027-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,979 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · derivative · entry 8 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,385 Underlying: Common Stock · 3,979 shares Expires 2027-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 123 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 123 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
SaleCommon Stock | 6,713 | $92.35 | $619,978.44 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,976 F4 · shares: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.045 to $93.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
Exercise / conversionCommon Stock | 6,713 | $37.29 | $250,327.77 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
SaleCommon Stock | 384 | $91.55 | $35,154.59 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,976 F3 · shares: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $91.89. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
SaleCommon Stock | 3,718 | $92.53 | $344,040.30 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,360 F2 · shares: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.91 to $92.91. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
Exercise / conversionCommon Stock | 123 | $35.48 | $4,364.04 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC |
Roberts David BDirector · President and Director
|
Exercise / conversionCommon Stock | 3,979 | $37.29 | $148,376.91 |
DisclosureSEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 12:54 UTC |
Roush John ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,561 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-25-026364 · rdgdoc.xml · derivative · entry 7 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,561 shares Expires 2025-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 12:54 UTC |
Roush John ADirector
|
SaleCommon Stock | 1,574 | $91.82 | $144,521.69 |
DisclosureSEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,916 F4 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $92.14. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 12:54 UTC |
Roush John ADirector
|
SaleCommon Stock | 4,987 | $92.78 | $462,708.82 |
DisclosureSEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,490 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.21 to $93.20. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 12:54 UTC |
Roush John ADirector
|
Exercise / conversionCommon Stock | 6,561 | $37.29 | $244,659.69 |
DisclosureSEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 12:55 UTC |
Ross Bridget ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-25-026366 · rdgdoc.xml · derivative · entry 3 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2025-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 12:55 UTC |
Ross Bridget ADirector
|
SaleCommon Stock | 2,500 | $94.00 | $235,000.00 |
DisclosureSEC source: 0001437749-25-026366 · rdgdoc.xml · nonDerivative · entry 2 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,916 Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 12:55 UTC |
Ross Bridget ADirector
|
Exercise / conversionCommon Stock | 2,500 | $37.29 | $93,225.00 |
DisclosureSEC source: 0001437749-25-026366 · rdgdoc.xml · nonDerivative · entry 1 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 12:54 UTC |
Roush John ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 939 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-25-026364 · rdgdoc.xml · derivative · entry 6 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,561 Underlying: Common Stock · 939 shares Expires 2025-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 12:54 UTC |
Roush John ADirector
|
SaleCommon Stock | 939 | $93.49 | $87,784.48 |
DisclosureSEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,916 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $93.025 to $94.00. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 12:54 UTC |
Roush John ADirector
|
Exercise / conversionCommon Stock | 939 | $37.29 | $35,015.31 |
DisclosureSEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 21:48 UTC |
LeMaitre George WDirector · Chairman and CEO
|
SaleCommon Stock | 100,000 | $93.51 | $9,350,530.00 |
DisclosureSEC source: 0001437749-25-025775 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,727,003 F1 · price: Adoption date of referenced 10b5-1(c) plan is: 03-10-2025 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $93.03 to $94.00. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
SHADAN MARTHADirector
|
GrantDividend Equivalent Rights · Derivative | 1.0387 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019171 · rdgdoc.xml · derivative · entry 5 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0397 Underlying: Common Stock · 1.0387 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/24 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/24 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/24 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
SHADAN MARTHADirector
|
GrantDividend Equivalent Rights · Derivative | 1.0208 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019171 · rdgdoc.xml · derivative · entry 4 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0145 Underlying: Common Stock · 1.0208 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
SHADAN MARTHADirector
|
GrantDividend Equivalent Rights · Derivative | 0.8524 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019171 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6837 Underlying: Common Stock · 0.8524 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
SHADAN MARTHADirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019171 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1096 Underlying: Common Stock · 0.4985 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
SHADAN MARTHADirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019171 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0983 Underlying: Common Stock · 0.4985 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
Roush John ADirector
|
GrantDividend Equivalent Rights · Derivative | 1.0387 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0397 Underlying: Common Stock · 1.0387 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
Roush John ADirector
|
GrantDividend Equivalent Rights · Derivative | 1.0208 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0145 Underlying: Common Stock · 1.0208 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
Roush John ADirector
|
GrantDividend Equivalent Rights · Derivative | 0.8524 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6837 Underlying: Common Stock · 0.8524 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
Roush John ADirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1096 Underlying: Common Stock · 0.4985 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:27 UTC |
Roush John ADirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0983 Underlying: Common Stock · 0.4985 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:25 UTC |
Ross Bridget ADirector
|
GrantDividend Equivalent Rights · Derivative | 1.0387 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 5 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0397 Underlying: Common Stock · 1.0387 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:25 UTC |
Ross Bridget ADirector
|
GrantDividend Equivalent Rights · Derivative | 1.0208 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 4 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0145 Underlying: Common Stock · 1.0208 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:25 UTC |
Ross Bridget ADirector
|
GrantDividend Equivalent Rights · Derivative | 0.8524 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 3 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6837 Underlying: Common Stock · 0.8524 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:25 UTC |
Ross Bridget ADirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 2 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1096 Underlying: Common Stock · 0.4985 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:25 UTC |
Ross Bridget ADirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 1 Ross Bridget A · CIK 0001698518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0983 Underlying: Common Stock · 0.4985 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:23 UTC |
Jasinski Lawrence JDirector
|
GrantDividend Equivalent Rights · Derivative | 1.0387 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0397 Underlying: Common Stock · 1.0387 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:23 UTC |
Jasinski Lawrence JDirector
|
GrantDividend Equivalent Rights · Derivative | 1.0208 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0145 Underlying: Common Stock · 1.0208 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:23 UTC |
Jasinski Lawrence JDirector
|
GrantDividend Equivalent Rights · Derivative | 0.8524 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6837 Underlying: Common Stock · 0.8524 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:23 UTC |
Jasinski Lawrence JDirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1096 Underlying: Common Stock · 0.4985 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:23 UTC |
Jasinski Lawrence JDirector
|
GrantDividend Equivalent Rights · Derivative | 0.4985 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0983 Underlying: Common Stock · 0.4985 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.